ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

32,045Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 5176

$3.21M Total Retail Price of All Prescriptions

Rank: 11 out of 5176

604 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 604 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 604 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 30,669 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

57% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$100 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

53 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
NEXIUM 1,470 1,423 1 16
METOPROLOL SUCCINATE 937 923 2 11
AMLODIPINE BESYLATE 851 832 3 2
METOPROLOL TARTRATE 808 782 4 6
ZOLPIDEM TARTRATE 690 645 5 17
JANUMET 650 615 6 77
ATORVASTATIN CALCIUM 575 552 7 9
SIMVASTATIN 559 539 8 1
PLAVIX 556 538 9 29
JANUVIA 528 507 10 25
DIOVAN 503 487 11 19
CREON 479 445 12 111
TAMSULOSIN HCL 475 464 13 20
FUROSEMIDE 446 437 14 8
LOVAZA 443 430 15 43
CARVEDILOL 437 410 16 24
CRESTOR 432 412 17 15
SYNTHROID 395 392 18 33
DEXILANT 393 390 19 118
COUMADIN 376 375 20 112
LEVOTHYROXINE SODIUM 375 332 21 4
ESCITALOPRAM OXALATE 333 324 22 89
CLOPIDOGREL 332 319 23 26
BENICAR 327 306 24 100
METFORMIN HCL 321 305 25 7
DIOVAN HCT 301 296 26 39
OMEPRAZOLE 298 277 27 3
LIDODERM 292 277 28 59
ENALAPRIL MALEATE 290 268 29 22
BENICAR HCT 288 258 30 110
ADVAIR DISKUS 269 253 31 32
ALCOHOL SWABS 260 253 32 115
PRANDIN 257 235 33 150
NAMENDA 251 251 34 47
ACTOS 234 229 35 85
LIPITOR 226 218 36 51
RAMIPRIL 226 221 36 50
ATENOLOL 218 218 38 12
DONEPEZIL HCL 217 217 39 28
MECLIZINE HCL 209 209 40 81
VYTORIN 207 182 41 152
RANEXA 205 204 42 167
LOSARTAN-HYDROCHLOROTHIAZIDE 202 199 43 35
ZETIA 202 202 43 68
LOSARTAN POTASSIUM 201 194 45 14
SPIRIVA 195 189 46 54
SPIRONOLACTONE 191 191 47 88
AVODART 173 173 48 107
HYDROCHLOROTHIAZIDE 168 159 49 10
DOXAZOSIN MESYLATE 165 164 50 103
ALLOPURINOL 165 162 50 41
GLIMEPIRIDE 162 162 52 37
PRADAXA 152 140 53 192
TRAMADOL HCL 151 147 54 40
ISOSORBIDE MONONITRATE ER 150 150 55 44
VOLTAREN 146 142 56 97
NIASPAN 146 135 56 175
DIGOXIN 144 140 58 56
VESICARE 143 143 59 210
AZITHROMYCIN 140 121 60 42
SOLARAZE 139 130 61 157
BYSTOLIC 137 121 62 96
LUNESTA 136 136 63 242
LYRICA 133 125 64 133
PROCTOZONE-HC 132 132 65 171
GABAPENTIN 131 119 66 21
LEXAPRO 131 127 66 193
CLONIDINE HCL 130 112 68 79
FINASTERIDE 130 119 68 69
CELEBREX 124 120 70 80
GLYBURIDE-METFORMIN HCL 119 119 R 71 76
PROPRANOLOL HCL 119 119 71 199
NIFEDIPINE ER 117 98 73 48
POLYETHYLENE GLYCOL 3350 117 115 73 74
ULORIC 116 107 75 280
LISINOPRIL 115 100 76 5
SIMCOR 109 108 10 77 507
FAMOTIDINE 108 105 78 58
LEVEMIR FLEXPEN 107 107 79 200
WARFARIN SODIUM 107 100 79 13
SINGULAIR 106 93 81 62
GLIPIZIDE 104 100 82 63
AMLODIPINE BESYLATE-BENAZEPRIL 104 104 82 55
RANITIDINE HCL 102 102 84 36
CILOSTAZOL 100 99 85 206
NITROSTAT 100 100 85 205
AZOR 99 99 87 194
TOPROL XL 99 97 87 227
AZELASTINE HCL 95 88 89 267
MELOXICAM 95 92 89 53
SERTRALINE HCL 92 92 91 30
LANSOPRAZOLE 91 85 92 113
FLUTICASONE PROPIONATE 91 91 92 38
IBANDRONATE SODIUM 91 91 92 211
PROAIR HFA 90 75 95 60
NASONEX 89 86 96 178
EXFORGE 89 87 96 126
NITROGLYCERIN PATCH 88 88 98 149
ONGLYZA 86 76 99 153
VICTOZA 3-PAK 86 84 99 322
POTASSIUM CHLORIDE 85 85 101 34
CIPROFLOXACIN HCL 85 81 101 84
CLOTRIMAZOLE-BETAMETHASONE 82 78 103 94
AGGRENOX 82 75 103 235
MULTAQ 81 81 105 414
BONIVA 81 68 105 236
VICTOZA 2-PAK 81 73 105 517
ROPINIROLE HCL 80 80 108 208
IBUPROFEN 78 64 109 72
LABETALOL HCL 74 64 110 114
QUINAPRIL HCL 73 61 111 82
GLIPIZIDE XL 72 68 112 83
ACTONEL 72 72 112 134
PRAVASTATIN SODIUM 71 70 114 23
PATANOL 70 70 115 158
ALENDRONATE SODIUM 70 60 115 18
DETROL LA 70 53 115 249
PEN NEEDLE 68 67 118 144
MICARDIS HCT 67 65 119 180
MIRTAZAPINE 67 67 119 45
ZOVIRAX 64 64 121 313
FLECTOR 62 56 122 282
TEKTURNA 62 62 122 255
QUETIAPINE FUMARATE 61 59 124 75
AMITIZA 60 60 125 197
SINGLE USE SWAB 60 59 125 108
PIOGLITAZONE HCL 59 54 R 127 237
CYMBALTA 59 59 127 90
CLOBETASOL PROPIONATE 58 58 129 130
SEROQUEL 56 56 130 166
MONTELUKAST SODIUM 54 48 131 123
LANTUS 53 52 132 66
MUPIROCIN 53 52 132 182
DICYCLOMINE HCL 52 50 134 224
BUMETANIDE 50 50 135 209
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.